神經血管導管市場 - 全球產業規模、佔有率、趨勢、機會及預測（按類型、應用、組件、最終用戶、地區和競爭格局分類），2021-2031年

全球神經血管導管市場預計將從 2025 年的 35.4 億美元成長到 2031 年的 54.1 億美元，複合年成長率為 7.32%。

這些專用醫療設備對於探索複雜的腦血管系統、診斷和治療顱內動脈瘤和缺血性中風等疾病至關重要。市場成長的主要驅動力是全球腦血管疾病發生率的上升趨勢，以及對微創血管內治療技術的強勁需求，因為與傳統開放性手術相比，微創血管內治療技術能夠提供更快的復健。最新統計數據也印證了這項需求：根據世界中風組織（WSO）預測，到2024年，全球將新增約1,200萬例中風病例，凸顯了高效介入治療的迫切性。

然而，由於產品研發成本高昂以及III類醫療設備監管核准流程嚴格，市場面臨許多障礙。這些財務和行政方面的障礙會延緩新技術的推廣應用，並限制其在成本敏感發展中市場的普及。因此，製造商不得不應對複雜的報銷機制和嚴格的合規要求，這共同阻礙了全球市場的成長。

市場促進因素

全球神經血管導管市場的主要促進因素是急性缺血性腦中風和腦動脈瘤發病率的不斷上升，而全球人口老化進一步加劇了這一趨勢。隨著老齡化成長，血管健康狀況下降，即時介入以預防死亡和長期殘疾的需求變得愈發迫切，迫使醫療系統必須配備有效的導管設備。根據美國心臟協會於2024年1月發布的《2024年心臟病和中風統計更新》，2021年美國約有1/21的死亡病例是由中風造成的，凸顯了這個問題的嚴重性。這項挑戰是全球性的，世界衛生組織（WHO）的一項重要分析報告顯示，到2021年，全球將有超過30億人患有神經系統疾病，這為神經血管診斷創造了龐大的患者群體。

同時，微創神經血管介入手術的日益普及和持續的技術創新正在推動市場成長。由於恢復時間更短且在複雜解剖結構中導航更為便捷，醫療專業人員擴大選擇血管內治療方法而非開放性手術。為此，製造商正在開發先進的抽吸和通路導管，以提高手術的安全性和有效性。這種向先進介入工具的轉變正在為主要市場參與企業帶來顯著的收入成長。例如，Penumbra公司在2024年2月報告稱，其截至2023年12月31日的會計年度全球血栓切除產品收入將達到6.773億美元，比上年成長32.5%，這充分體現了技術創新如何推動市場擴張。

市場挑戰

高昂的產品研發成本，加上嚴格的監管核准程序，對全球神經血管導管市場的成長構成了重大障礙。這些導管被歸類為III類醫療設備，必須接受嚴格的監管審查，需要進行耗資巨大且大規模的臨床試驗，以證明其在脆弱的腦血管中的安全性和有效性。這種嚴格的上市前流程延長了研發週期，並給資金不足但具有創新精神的中小型企業造成了巨大的財務障礙。因此，該行業仍然由少數幾家大型企業主導，削弱了價格競爭，並減緩了新技術的引入。

此外，嚴峻的監管環境迫使企業將大量資源從創新轉移到合規和認證維護。近期行業數據顯示，滿足這些標準帶來的日益沉重的財務負擔：根據歐洲醫療技術協會 (MedTech Europe) 2025 年的一項調查，醫療設備製造商預計，未來五年內，與監管維護和重新認證相關的成本將增加 50%。不斷上漲的營運成本迫使製造商優先考慮成熟的、高回報的市場以獲得投資回報，而忽略了對價格敏感、中風發病率不斷上升的發展中地區。這種情況有效地限制了市場的整體覆蓋範圍，並抑制了全球成長速度。

市場趨勢

為了克服手動操作導管的局限性，市場正日益採用機器人輔助系統。這些系統在複雜的神經血管手術中提供卓越的穩定性和精準度，能夠實現亞毫米級的器械控制，顯著降低血管損傷的風險，並為遠距介入治療開闢了道路。遠端機器人技術的轉變使專家能夠遠端進行手術，有助於緩解醫療資源匱乏地區介入神經放射學短缺的問題。例如，2024年12月，MicroRobot Medical公司宣布成功完成了一項模擬遠距手術，手術地點相距五英里，在向FDA提交申請之前，就已證明了遠距血管內手術的技術可行性。

同時，由於直接抽吸首過技術（ADAPT）能夠快速有效地重組，臨床醫師正將其作為機械取栓的主要方法。這種轉變推動了對大口徑抽吸導管的需求，這些導管的設計旨在提供強大的吸力以清除血栓。由於醫生更傾向於使用這些專用器械而非傳統的血栓摘取支架來治療急性缺血性腦中風，製造商在該領域正經歷著強勁的成長。根據史賽克公司2025年1月發布的報告，該公司醫療外科和神經技術部門2024會計年度全年淨銷售額預計將成長11.1%，顯示市場對先進介入神經放射學技術的需求將持續旺盛。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球神經血管導管市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依類型（微導管、球囊導管、通路導管、栓塞導管、其他）
  • 依應用領域（細胞栓塞、腦動脈瘤、動靜脈畸形等）
  • 依組件分類（導管芯軸、導管襯裡、回流焊接熱縮管、尼龍管/Pebax、其他）
  • 依最終使用者（醫院/診所、門診手術中心、其他）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美神經血管導管市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲神經血管導管市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區神經血管導管市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲神經血管導管市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲神經血管導管市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球神經血管導管市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Medtronic plc
• Stryker Corporation
• Johnson & Johnson
• Penumbra, Inc.
• Terumo Corporation
• MicroVention, Inc.
• Integer Holdings Corporation
• Boston Scientific Corporation
• Asahi Intecc Co., Ltd.
• B. Braun Melsungen AG

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Neurovascular Catheters Market is projected to expand from USD 3.54 Billion in 2025 to USD 5.41 Billion by 2031, registering a CAGR of 7.32%. These specialized medical instruments are essential for navigating complex cerebral vasculature to diagnose and treat disorders like intracranial aneurysms and ischemic strokes. Market momentum is primarily fueled by the growing global burden of cerebrovascular diseases and a strong preference for minimally invasive endovascular techniques, which offer faster recovery than traditional open surgeries. Recent statistics underscore this demand; according to the World Stroke Organization, approximately 12 million new stroke cases were documented worldwide in 2024, emphasizing the urgent necessity for efficient interventional therapies.

However, the market encounters substantial hurdles due to the exorbitant costs associated with product development and the rigorous regulatory approval frameworks mandated for these Class III medical devices. Such financial and bureaucratic obstacles can postpone the release of new technologies and restrict their availability in cost-sensitive developing markets. As a result, manufacturers are compelled to manage intricate reimbursement structures and strict compliance requirements, which collectively hinder the speed of global market growth.

Market Driver

The principal factor propelling the Global Neurovascular Catheters Market is the increasing prevalence of acute ischemic strokes and cerebral aneurysms, a trend aggravated by the aging global population. As vascular health declines with age, the need for immediate interventions to avert mortality and long-term disability becomes more critical, compelling healthcare systems to secure effective catheterization devices. Data from the American Heart Association's '2024 Heart Disease and Stroke Statistics Update' in January 2024 indicates that stroke caused roughly 1 out of every 21 deaths in the United States in 2021, highlighting the severity of the issue. This challenge is widespread; a major 2024 analysis by the World Health Organization reported that over 3 billion individuals globally were living with a neurological condition in 2021, creating a massive patient base for neurovascular diagnostics.

Concurrently, market growth is bolstered by the rising utilization of minimally invasive neuroendovascular procedures and ongoing technological innovation. Medical professionals are increasingly favoring endovascular methods over open surgery because of shorter recovery periods and better navigation through tortuous anatomies. In response, manufacturers are creating advanced aspiration and access catheters to improve procedural safety and effectiveness. This pivot toward sophisticated interventional tools is yielding significant revenue growth for major industry participants. For example, Penumbra, Inc. reported in February 2024 that revenue from their global thrombectomy products reached $677.3 million for the year ending December 31, 2023, a 32.5% increase from the previous year, demonstrating how innovation drives market expansion.

Market Challenge

The combination of high product development costs and stringent regulatory approval procedures presents a major obstacle to the growth of the Global Neurovascular Catheters Market. Categorized as Class III medical devices, these catheters face intense regulatory scrutiny, requiring expensive and extensive clinical trials to prove their safety and efficacy within fragile cerebral blood vessels. This demanding pre-market process creates a significant financial hurdle that extends development timelines and deters smaller, innovative companies lacking sufficient capital. Consequently, the industry remains dominated by a handful of large corporations, which diminishes competitive pricing dynamics and decelerates the launch of new technologies.

Furthermore, this difficult regulatory landscape forces companies to divert essential resources from innovation to compliance and certification maintenance. The growing financial strain of meeting these standards is highlighted by recent industry data; according to a 2025 survey by MedTech Europe, medical device manufacturers anticipate a 50% rise in costs associated with regulatory maintenance and re-certification over a five-year period. These increasing operational costs compel manufacturers to prioritize established, high-margin markets to recoup their investments, often neglecting price-sensitive developing regions where stroke prevalence is rising. This situation effectively limits the market's total reach and suppresses global growth rates.

Market Trends

The market is increasingly adopting robotic-assisted systems to mitigate the constraints of manual catheter navigation, providing superior stability and precision during intricate neurovascular surgeries. This technology enables sub-millimeter accuracy in device control, drastically lowering the risk of vessel damage while opening possibilities for remote interventions. The move toward telerobotics helps address the shortage of neurointerventional specialists in underserved areas by allowing experts to perform procedures from distinct locations. For instance, in December 2024, Microbot Medical announced the successful completion of a simulated telesurgery between two sites five miles apart, confirming the technical viability of remote endovascular operations ahead of their FDA submission.

Simultaneously, clinicians are standardizing the Direct Aspiration First Pass Technique (ADAPT) as a primary method for mechanical thrombectomy due to its rapid and effective revascularization capabilities. This shift is fueling demand for large-bore aspiration catheters engineered with maximized inner lumens to provide powerful suction for clot removal. As physicians favor these specialized tools over conventional stent retrievers for treating acute ischemic stroke, manufacturers are seeing strong growth in this segment. According to Stryker's January 2025 report, net sales for their MedSurg and Neurotechnology segment rose by 11.1% for the full year 2024, indicating sustained demand for advanced neurointerventional technologies.

Key Market Players

• Medtronic plc
• Stryker Corporation
• Johnson & Johnson
• Penumbra, Inc.
• Terumo Corporation
• MicroVention, Inc.
• Integer Holdings Corporation
• Boston Scientific Corporation
• Asahi Intecc Co., Ltd.
• B. Braun Melsungen AG

Report Scope

In this report, the Global Neurovascular Catheters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurovascular Catheters Market, By Type

• Microcatheters
• Balloon Catheters
• Access Catheters
• Embolization Catheters
• Others

Neurovascular Catheters Market, By Application

• Cell Embolic Stroke
• Brain Aneurysms
• Arteriovenous Malformations
• Others

Neurovascular Catheters Market, By Component

• Catheter Mandrels
• Catheter Liners
• Reflow Heat Shrinks
• Nylon Tubing/Pebax
• Others

Neurovascular Catheters Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Neurovascular Catheters Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Neurovascular Catheters Market.

Available Customizations:

Global Neurovascular Catheters Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Neurovascular Catheters Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters, Others)
  • 5.2.2. By Application (Cell Embolic Stroke, Brain Aneurysms, Arteriovenous Malformations, Others)
  • 5.2.3. By Component (Catheter Mandrels, Catheter Liners, Reflow Heat Shrinks, Nylon Tubing/Pebax, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Neurovascular Catheters Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Component
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Neurovascular Catheters Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Component
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Neurovascular Catheters Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Component
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Neurovascular Catheters Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Component
      • 6.3.3.2.4. By End User

7. Europe Neurovascular Catheters Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Component
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Neurovascular Catheters Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Component
      • 7.3.1.2.4. By End User
  • 7.3.2. France Neurovascular Catheters Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Component
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Neurovascular Catheters Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Component
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Neurovascular Catheters Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Component
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Neurovascular Catheters Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Component
      • 7.3.5.2.4. By End User

8. Asia Pacific Neurovascular Catheters Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Component
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Neurovascular Catheters Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Component
      • 8.3.1.2.4. By End User
  • 8.3.2. India Neurovascular Catheters Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Component
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Neurovascular Catheters Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Component
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Neurovascular Catheters Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Component
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Neurovascular Catheters Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Component
      • 8.3.5.2.4. By End User

9. Middle East & Africa Neurovascular Catheters Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Component
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Neurovascular Catheters Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Component
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Neurovascular Catheters Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Component
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Neurovascular Catheters Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Component
      • 9.3.3.2.4. By End User

10. South America Neurovascular Catheters Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Component
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Neurovascular Catheters Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Component
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Neurovascular Catheters Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Component
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Neurovascular Catheters Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Component
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Neurovascular Catheters Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Stryker Corporation
• 15.3. Johnson & Johnson
• 15.4. Penumbra, Inc.
• 15.5. Terumo Corporation
• 15.6. MicroVention, Inc.
• 15.7. Integer Holdings Corporation
• 15.8. Boston Scientific Corporation
• 15.9. Asahi Intecc Co., Ltd.
• 15.10. B. Braun Melsungen AG

16. Strategic Recommendations

17. About Us & Disclaimer